Hepatitis A to E in People with HIV: A Virus-Specific Review of Prevention and Treatment

Lin KY, Fang CT. Public health responses to person-to-person hepatitis A outbreaks. J Infect Dis. 2021;223(3):359–61.

Article  PubMed  Google Scholar 

Ndumbi P, Freidl GS, Williams CJ, et al. Hepatitis A outbreak disproportionately affecting men who have sex with men (MSM) in the European Union and European Economic Area, June 2016 to May 2017. Euro Surveill. 2018;23(33):1700641.

Article  PubMed  PubMed Central  Google Scholar 

Yoshimura Y, Horiuchi H, Sawaki K, et al. Hepatitis A outbreak among men who have sex with men, Yokohama, Japan, January to May 2018. Sex Transm Dis. 2019;46(3):e26–7.

Article  PubMed  Google Scholar 

Tanaka S, Kishi T, Ishihara A, et al. Outbreak of hepatitis A linked to European outbreaks among men who have sex with men in Osaka, Japan, from March to July 2018. Hepatol Res. 2019;49(6):705–10.

Article  PubMed  Google Scholar 

Mariojoules J, Castro G, Pisano MB, et al. Hepatitis A outbreak affecting men who have sex with men (MSM) in central Argentina, occurred in July 2017-April 2018, later than the European outbreak. J Clin Virol. 2019;117:49–53.

Article  PubMed  Google Scholar 

Snyder MR, McGinty MD, Shearer MP, Meyer D, Hurtado C, Nuzzo JB. Outbreaks of hepatitis A in US communities, 2017–2018: firsthand experiences and operational lessons from public health responses. Am J Public Health. 2019;109(S4):S297-302.

Article  PubMed  PubMed Central  Google Scholar 

Sachdeva H, Benusic M, Ota S, et al. Community outbreak of hepatitis A disproportionately affecting men who have sex with men in Toronto, Canada, January 2017-November 2018. Can Commun Dis Rep. 2019;45(10):262–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kang M, Horman SF, Taplitz RA, et al. Public health role of academic medical center in community outbreak of hepatitis A, San Diego County, California, USA, 2016–2018. Emerg Infect Dis. 2020;26(7):1374–81.

Article  PubMed  PubMed Central  Google Scholar 

Brouwer AF, Zelner JL, Eisenberg MC, et al. The impact of vaccination efforts on the spatiotemporal patterns of the hepatitis A outbreak in Michigan, 2016–2018. Epidemiology. 2020;31(5):628–35.

Article  PubMed  PubMed Central  Google Scholar 

Marciano S, Arufe D, Haddad L, et al. Outbreak of hepatitis A in a post-vaccination era: high rate of co-infection with sexually transmitted diseases. Ann Hepatol. 2020;19(6):641–4.

Article  PubMed  Google Scholar 

Honda M, Asakura H, Kanda T, et al. Male-dominant hepatitis A outbreak observed among non-HIV-infected persons in the northern part of Tokyo, Japan. Viruses. 2021;13(2):207.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gozlan Y, Bar-Or I, Volnowitz H, et al. Lessons from intensified surveillance of viral hepatitis A, Israel, 2017 and 2018. Euro Surveill. 2021;26(6):2000001.

Article  PubMed  PubMed Central  Google Scholar 

Batdorf SJ, Hofmeister MG, Surtees TC, Thomasson ED, McBee SM, Pauly NJ. Estimated medicaid costs associated with hepatitis A during an outbreak - West Virginia, 2018–2019. MMWR Morb Mortal Wkly Rep. 2021;70(8):269–72.

Article  PubMed  PubMed Central  Google Scholar 

Dankwa EA, Donnelly CA, Brouwer AF, et al. Estimating vaccination threshold and impact in the 2017–2019 hepatitis A virus outbreak among persons experiencing homelessness or who use drugs in Louisville, Kentucky, United States. Vaccine. 2021;39(49):7182–90.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Itaki M, Endo M, Asakura H, et al. Hepatitis A outbreak among men who have sex with men, Shinjuku, Japan, 2018. Western Pac Surveill Response J. 2025;16(1):1–10.

PubMed  PubMed Central  Google Scholar 

Hofmeister MG, Xing J, Foster MA, et al. Hepatitis A person-to-person outbreaks: epidemiology, morbidity burden, and factors associated with hospitalization-multiple states, 2016-2019. J Infect Dis. 2021;223(3):426–34.

Article  PubMed  Google Scholar 

Lee YL, Chen GJ, Chen NY, et al. Less severe but prolonged course of acute hepatitis A in human immunodeficiency virus (HIV)-infected patients compared with HIV-uninfected patients during an outbreak: a multicenter observational study. Clin Infect Dis. 2018;67(10):1595–602.

Article  PubMed  Google Scholar 

Lin KY, Chen GJ, Lee YL, et al. Hepatitis A virus infection and hepatitis A vaccination in human immunodeficiency virus-positive patients: a review. World J Gastroenterol. 2017;23(20):3589–606.

Article  PubMed  PubMed Central  Google Scholar 

Kazzi B, Naji A, Dib SM, et al. Efficacy and durability of immune response after receipt of hepatitis A vaccine in people with human immunodeficiency virus. Open Forum Infect Dis. 2025;12(4):ofaf143.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shire NJ, Welge JA, Sherman KE. Efficacy of inactivated hepatitis A vaccine in HIV-infected patients: a hierarchical bayesian metaanalysis. Vaccine. 2006;24(3):272–9.

Article  CAS  PubMed  Google Scholar 

Lin KY, Hsieh SM, Sun HY, et al. Serologic responses and effectiveness of hepatitis A vaccination among human immunodeficiency virus-positive individuals during the outbreak of acute hepatitis A. Hepatology. 2018;68(1):22–31.

Article  CAS  PubMed  Google Scholar 

Neukam K, Delgado Fernández M, Hernández Quero J, et al. Brief report: response to hepatitis A virus vaccine in HIV-infected patients within a retrospective, multicentric cohort: facing hepatitis A outbreaks in the clinical practice. J Acquir Immune Defic Syndr. 2019;81(1):e1–5.

Article  PubMed  Google Scholar 

Noël L, Tubiana R, Simon A, et al. Low immune response rate of HIV-infected patients to a single injection of hepatitis A vaccine. Infect Dis Now. 2021;51(1):94–6.

Article  PubMed  Google Scholar 

Tsai PH, Tsai MS, Chiang YH, et al. Effectiveness of hepatitis A vaccination among people living with HIV in Taiwan: is one dose enough? J Microbiol Immunol Infect. 2022;55(1):18–25.

Article  CAS  PubMed  Google Scholar 

Koga M, Senkoji T, Kubota M, et al. Predictors associated with a better response to the Japanese aluminum-free hepatitis A vaccine, Aimmugen(®), for people living with HIV. Hepatol Res. 2022;52(3):227–34.

Article  CAS  PubMed  Google Scholar 

Schnyder JL, Garcia Garrido HM, Tanck MW, et al. Hepatitis a vaccine immunogenicity and boostability in adults receiving immunosuppressive therapy and adults living with HIV: a prospective single-centre cohort study. J Travel Med. 2025;32(2):taae125.

Article  PubMed  Google Scholar 

Fritzsche C, Bergmann L, Loebermann M, Glass A, Reisinger EC. Immune response to hepatitis A vaccine in patients with HIV. Vaccine. 2019;37(16):2278–83.

Article  CAS  PubMed  Google Scholar 

Huang SH, Huang CH, Wang NC, et al. Early seroreversion after 2 doses of hepatitis A vaccination in human immunodeficiency virus-positive patients: incidence and associated factors. Hepatology. 2019;70(2):465–75.

Article  CAS  PubMed  Google Scholar 

Lin KY, Sun HY, Huang YS, et al. Durability of serologic responses to inactivated hepatitis A virus vaccination among people living with HIV following acute hepatitis A outbreak: a 5-year follow-up study. Emerg Microbes Infect. 2023;12(2):2239946.

Article  PubMed  PubMed Central  Google Scholar 

Koga M, Saito M, Kubota M, et al. Attenuation of hepatitis A antibody after immunization with hepatitis A vaccine (Aimmugen) in people living with HIV. Hepatol Res. 2024;54(5):487–94.

Article  CAS  PubMed  Google Scholar 

Chen GJ, Sun HY, Lin KY, et al. A randomized clinical trial of 1-dose vs accelerated 2-dose schedule for hepatitis A virus (HAV) revaccination among people with human immunodeficiency virus who were nonresponders or had seroreversion after primary HAV vaccination. Clin Infect Dis. 2023;77(4):529–36.

Article  CAS  PubMed 

Comments (0)

No login
gif